• development-based life sciences
  • development-based life sciences

Shareholder and Investor Information

  • Understanding RaQualia Pharma! RaQualia FAQ
  • Stock Quotes (20 min. delay) JQC
    Stock Information
    powered by Stock Weather

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
5-HT4 Partial Agonist
(RQ-00000010)
Acid Pump Antagonist
5-HT2B Antagonist
Motilin Receptor Agonist
EP4 Antagonist
Cyclooxygenase-2 (COX-2) Inhibitor
5-HT4 Partial Agonist
(RQ-00000009)
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Stock Quotes
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics